Screener
MoonLake Immunotherapeutics MLTX United Kingdom — Long-Lived Assets
Other geography segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by MoonLake Immunotherapeutics in its filing.
Tagged under the XBRL concept us-gaap:NoncurrentAssets.
The source filing: MoonLake Immunotherapeutics’s 10-Q, filed May 11, 2026.
- Filed
- May 11, 2026, 8:55 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001821586-26-000007
FAQ
- What is MoonLake Immunotherapeutics's united kingdom — long-lived assets?
- MoonLake Immunotherapeutics (MLTX) reported united kingdom — long-lived assets of $553K in Q1 2026.
- How has MoonLake Immunotherapeutics's united kingdom — long-lived assets changed year-over-year?
- MoonLake Immunotherapeutics's united kingdom — long-lived assets decreased by 64.0% year-over-year, from $1.54M to $553K.
- What does united kingdom — long-lived assets mean?
- This metric represents the total book value of non-current, tangible, and intangible assets physically located or legally domiciled within the United Kingdom. It reflects the company's investment in regional infrastructure, research facilities, or intellectual property holdings specific to this geographic market. Monitoring this value helps investors assess the company's operational footprint and capital allocation strategy within the UK regulatory and economic environment.
Ask your AI about MoonLake Immunotherapeutics's united kingdom — long-lived assets.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude